The Government is investing in a Strategic Science Investment Fund (SSIF) platform for Ribonucleic Acid (RNA) development. This is to ensure New Zealand has well-connected and world-class research capability to strengthen the use and commercialisation of RNA technology.
Passing new employment leave legislation is a priority for the Government.
The Government is investing in an Infectious Disease research platform to ensure New Zealand has world class research capability to respond to serious infectious disease threats.
This research collates and analyses emissions and waste stream data for the advanced manufacturing sector. The information is presented by subsector and allows for analysis of where significant and targeted impacts can be made for emissions and waste reduction.
This section is provided as a summary of the current state of AEP for your information only. We are not seeking feedback on this section.
Proposed Companies Office fees and levies set to recover $42 million expenditure.
We deliver a range of data, statistics, modelling, research and analytical papers.
An overview of the key research, data, and media releases in August 2021.
Crown copyright © 2026
https://www.mbie.govt.nz/search
Please note: This content will change over time and can go out of date.